Process / pipelinedisease-specific walking disability

Multiple Sclerosis Walking Scale-12 (MSWS-12)

The MSWS-12 is a brief, patient-reported outcome measure specifically designed to assess the impact of multiple sclerosis on walking ability and limitation. Developed by Hobart and colleagues in 2003, this 12-item scale captures both the physical difficulty and functional consequences of MS-related gait impairment. It is highly responsive to change and widely used in MS clinical trials and practice as a primary outcome measure for assessing intervention effects on mobility.

Open in MethodMindSoonVideoSoon

Read the full method

Members only

Sign in with a free account to read this section.

Sign in

Sources

  1. Hobart, J. C., Riazi, A., Lamping, D. L., Fitzpatrick, R., & Thompson, A. J. (2003). Measuring the impact of MS on walking ability: The 12-Item MS Walking Scale (MSWS-12). Neurology, 60(1), 31-36. DOI: 10.1212/WNL.60.1.31

Related methods

Referenced by

ScholarGateMSWS-12 (Multiple Sclerosis Walking Scale-12). Retrieved 2026-06-04 from https://scholargate.app/en/neurology/msws-12